0001553350-17-001214.txt : 20171113 0001553350-17-001214.hdr.sgml : 20171110 20171113161159 ACCESSION NUMBER: 0001553350-17-001214 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SMSA CRANE ACQUISITION CORP. CENTRAL INDEX KEY: 0001473287 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 270984742 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53800 FILM NUMBER: 171195963 BUSINESS ADDRESS: STREET 1: 4 ORINDA WAY STREET 2: SUITE 180-C CITY: ORINDA STATE: CA ZIP: 94563 BUSINESS PHONE: (925) 791-1440 MAIL ADDRESS: STREET 1: 4 ORINDA WAY STREET 2: SUITE 180-C CITY: ORINDA STATE: CA ZIP: 94563 10-Q 1 sscr_10q.htm QUARTERLY REPORT Quarterly Report

 


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


(Mark One)


þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended: September 30, 2017


¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _____________ to _____________


Commission File Number: 000-53800


SMSA Crane Acquisition Corp.

(Exact name of registrant as specified in its charter)


Nevada

27-0984742

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)


4 Orinda Way, Suite 180-C, Orinda, CA  94563

(Address of principal executive offices, Zip Code)


(925) 791-1440

(Registrant's telephone number, including area code)

________________________________________________________

(Former Name, Former Address and Former Fiscal Year if Changed Since Last Report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No ¨


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨  No þ


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large Accelerated Filer ¨

Non-Accelerated Filer ¨

Accelerated Filer ¨

Smaller reporting company þ

 

 (Do not check if a smaller reporting company)

Emerging growth company ¨

 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes þ  No ¨


State the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date: 10,047,495 common shares as of November 6, 2017.

 

 





 


TABLE OF CONTENTS


 

 

Page

                     

 

                     

 

PART I – FINANCIAL INFORMATION

 

 

 

 

Item 1.

Condensed Financial Statements

1

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

9

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

11

Item 4.

Controls and Procedures

12

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

13

Item 1A.

Risk Factors

13

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

13

Item 3.

Defaults Upon Senior Securities

13

Item 4.

Mine Safety Disclosures

13

Item 5.

Other Information

13

Item 6.

Exhibits

13









 


PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.


Our financial statements included in this Form 10-Q are as follows:

 

2

Condensed Balance Sheets as of September 30, 2017 (unaudited) and December 31, 2016;

3

Condensed Statements of Operations for the three and nine months ended September 30, 2017 and 2016 (unaudited);

4

Condensed Statements of Cash Flows for the nine months ended September 30, 2017 and 2016 (unaudited);

5

Notes to Condensed Financial Statements.

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended September 30, 2017 are not necessarily indicative of the results that can be expected for the full year.




1



 


SMSA Crane Acquisition Corp.

Condensed Balance Sheets


 

 

September 30,

 

 

December 31,

 

 

 

2017

 

 

2016

 

 

 

(Unaudited)

 

 

 

 

ASSETS

  

                           

  

  

                           

  

Current Assets

 

 

 

 

 

 

Cash – attorney escrow account

 

$

29,869

 

 

$

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

29,869

 

 

$

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

2,920

 

 

$

83,272

 

Due to shareholder

 

 

39,115

 

 

 

 

Due to former shareholder

 

 

 

 

 

155,670

 

Due to related party

 

 

 

 

 

5,405

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

42,035

 

 

 

244,347

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit

 

 

 

 

 

 

 

 

Preferred stock - $0.001 par value, 10,000,000 shares authorized. None issued and outstanding

 

 

 

 

 

 

Common stock - $0.001 par value, 100,000,000 shares authorized. 10,047,495 shares and 11,663,448 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively

 

 

10,048

 

 

 

11,664

 

Additional paid-in capital

 

 

338,357

 

 

 

49,546

 

Accumulated deficit

 

 

(360,571

)

 

 

(305,557

)

 

 

 

 

 

 

 

 

 

Total Stockholders' Deficit

 

 

(12,166

)

 

 

 (244,347

)

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Deficit

 

$

29,869

 

 

$

 


The accompanying notes are an integral part of these condensed financial statements.




2



 



SMSA Crane Acquisition Corp.

Condensed Statements of Operations

 (Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

 

8,845

 

 

 

717

 

 

 

45,845

 

 

 

1,240

 

Other general and administrative expenses

 

 

3,321

 

 

 

158

 

 

 

9,169

 

 

 

461

 

Total operating expenses

 

 

12,166

 

 

 

875

 

 

 

55,014

 

 

 

1,701

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(12,166

)

 

 

(875

)

 

 

(55,014

)

 

 

(1,701

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$

(12,166

)

 

$

(875

)

 

$

(55,014

)

 

$

(1,701

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per weighted-average share of common stock outstanding, computed on net loss - basic and fully diluted

 

$

(0.00

)

 

$

(0.00

)

 

$

(0.01

)

 

$

(0.00

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares of common stock outstanding - basic and fully diluted

 

 

10,047,495

 

 

 

11,663,448

 

 

 

10,245,213

 

 

 

11,663,448

 


The accompanying notes are an integral part of these condensed financial statements.




3



 



SMSA Crane Acquisition Corp.

Condensed Statements of Cash Flows

 (Unaudited)


 

 

Nine Months Ended

 

 

 

September 30,

 

 

 

2017

 

 

2016

 

Cash Flows from Operating Activities:

  

                           

  

  

                           

  

Net loss for the period

 

$

(55,014

)

 

$

(1,701

)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

Changes in operating working capital items:

 

 

 

 

 

 

 

 

Accounts payable

 

 

49,648

 

 

 

(878

)

Net Cash Used in Operating Activities

 

$

(5,366

)

 

$

(2,579

)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Repayment to a related party

 

 

(5,405

)

 

 

 

Advance from shareholder

 

 

39,115

 

 

 

 

Advance from a former shareholder

 

 

1,525

 

 

 

2,579

 

Net Cash Provided by Financing Activities

 

$

35,235

 

 

$

2,579

 

 

 

 

 

 

 

 

 

 

Increase in Cash

 

 

29,869

 

 

 

 

Cash at beginning of period

 

 

 

 

 

 

Cash at end of period

 

$

29,869

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Interest and Income Taxes Paid:

 

 

 

 

 

 

 

 

Interest paid during the period

 

$

 

 

$

 

Income taxes paid during the period

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Non- cash Flow Investing and Financing Activities:

 

 

 

 

 

 

 

 

Cancellation of shares

 

$

1,663

 

 

$

 

Shares issued for debt

 

$

157,195

 

 

$

 

Forgiveness of debt

 

$

130,000

 

 

$

 



The accompanying notes are an integral part of these condensed financial statements.



4



 


SMSA Crane Acquisition Corp.

Notes to Unaudited Condensed Financial Statements

September 30, 2017


Note A - Basis of presentation, Background and Description of Business


Basis of presentation


The accompanying unaudited condensed financial statements of SMSA Crane Acquisition Corp. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited financial statements for the year ended December 31, 2016, included in our Annual Report on Form 10-K for the year ended December 31, 2016.


In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine month periods have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms "Company", "we", "us" or "our" mean SMSA Crane Acquisition Corp.


Background and Description of Business


SMSA Crane Acquisition Corp. was organized on September 9, 2009 as a Nevada corporation to effect the reincorporation of Senior Management Services of Crane, Inc., a Texas corporation, mandated by the plan of reorganization discussed below.


The Company's emergence from Chapter 11 of Title 11 of the United States Code on August 1, 2007 caused a change in majority ownership and voting control - that is, loss of control by the then-existing stockholders, a court-approved reorganization, and a reliable measure of the entity's fair value - resulting in a fresh start, creating, in substance, a new reporting entity. Accordingly, the Company, post-bankruptcy, had no significant assets, liabilities or operating activities. Therefore, the Company, as a new reporting entity, qualified as a shell company as defined in Rule 405 under the Securities Act of 1933, and Rule 12b-2 under the Securities Exchange Act of 1934. The Company's Plan of Reorganization (the "Plan") was confirmed by the United States Bankruptcy Court, Northern District of Texas – Dallas Division on August 1, 2007 and became effective on August 10, 2007.


On August 29, 2013, Coquí Radio Pharmaceuticals, Corp. ("Coquí") closed a transaction through which Coquí purchased 9,500,000 outstanding shares of common stock and agreed to purchase an additional 400,000 outstanding shares of common stock of the Company from existing shareholders in a private transaction in exchange for $280,000. The additional 400,000 shares were subsequently acquired on October 24, 2013 and Coquí became the majority controlling stockholder of the Company.


The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. The Company is not restricting its potential target companies to any specific business, industry or geographical location. No assurances can be given that the Company will be successful in locating or negotiating with any target company.


Note B - Change of Control


Coqui the principal shareholder of the Company entered the Stock Purchase Agreement, effective as of the 26th day of June, 2017, with Irwin Eskanos (“Buyer”).  Coqui agreed to sell to the Buyer, and the Buyer agreed to purchase from Coqui, a total of 9,947,490 shares of common stock of the Company for a total purchase price of $250,000.  These purchased shares represented approximately 99.00% of the Company’s issued and outstanding shares of Common Stock. Also, concurrently with the sale of controlling interest, Coqui paid all outstanding liabilities of the Company as of the date of this sale. As a result, Coqui paid $130,000 of the Company’s outstanding accounts payable through the attorney’s escrow accounts and agreed to forgive all of its debts at the closing of this transaction. The Company recorded Coqui’s forgiveness of debt of $130,000 under Additional paid in capital, for the three months and nine months ended September 30, 2017.


On June 26, 2017, the board of directors appointed Irwin Eskanos as our new sole Director, President, Secretary, Treasurer, CEO, and CFO. Following these appointments, the board accepted the resignation of Carmen I. Bigles as our former sole officer and director.




5



 


Note C – Going Concern


We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. Our net losses incurred for the nine months ended September 30, 2017 and 2016, amounted to approximately $55,000 and $1,700, respectively, and working capital (deficits) was approximately $(12,000) and $(244,000), respectively, at September 30, 2017 and December 31, 2016. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available.


Note D - Summary of Significant Accounting Policies and Recent Accounting Pronouncements


Use of Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.


Cash and cash equivalents


The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.


Income taxes


The Company files income tax returns in the United States of America and various states, as appropriate and applicable.


The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.


The Company has adopted the provisions of ASC 740-10 "Accounting for Uncertain Income Tax Positions". The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a "more-likely-than-not" probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.


Income (Loss) per share


Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.


Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants).


Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position at the calculation date.

 

As of September 30, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. At September 30, 2017 there were 0 outstanding common stock warrants, which could dilute future earnings per share.




6



 


Recently Adopted Accounting Pronouncements


Going Concern


ASU 2014-15 – “Presentation of Financial Statements—Going Concern—Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”).” In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The updated accounting guidance was effective for the Company on December 31, 2016. We have implemented this new accounting standard and we will update our liquidity disclosures as necessary.


Recent Accounting Pronouncements


Recently-Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.


Income Taxes


In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory ("ASU 2016-16"), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its financial statements.


Note E - Fair Value of Financial Instruments and fair value measurements


The carrying amount of cash, accounts payable and accrued expenses and due to stockholder, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.


The carrying amount of due to the shareholder and accrued liabilities, as applicable, approximates fair value due to the short-term nature of these items. The fair value of the related party notes payable cannot be determined because of the Company's affiliation with the parties with whom the agreements exist. The carrying amount approximates its fair value at September 30, 2017 and December 31, 2016. The use of different assumptions or methodologies may have a material effect on the estimates of fair values.


ASC Topic 820, "Fair Value Measurements and Disclosures," requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, "Financial Instruments," defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

·

Level 1:

Observable inputs such as quoted prices in active markets;

 

 

 

·

Level 2:

Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

 

 

·

Level 3:

Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.


Note F - Due to Shareholder


As of September 30, 2017 and December 31, 2016, the Company owes $39,115 and $0, respectively, to Mr. Irwin Eskanos, the principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.


Note G - Due to Former Shareholder


As of September 30, 2017 and December 31, 2016, the Company owes $0 and $155,670, respectively, to Coquí, the former principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.




7



 


Note H - Due to Related Party


As of September 30, 2017 and December 31, 2016, the Company owes $0 and $5,405, respectively, to Ms. Carmen I. Bigles, our former Chief Executive Officer and sole Director of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.


Note I - Concentration of Credit Risk


At times cash deposited with financial institutions may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2017.


Note J - Contingencies


The Company was contemplating a possible merger by the Company and Coquí. The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. No assurances can be given that the Company will be successful in pursuing a business combination in the near future or at all.


Note K- Stockholders' Deficit


Pursuant to our Articles of Incorporation, our board has the authority, without further stockholder approval, to provide for the issuance of up to 10,000,000 shares of our preferred stock in one or more series and to determine the dividend rights, conversion rights, voting rights, rights in terms of redemption, liquidation preferences, the number of shares constituting any such series and the designation of such series. Our board has the power to afford preferences, powers and rights (including voting rights) to the holders of any preferred stock preferences, such rights and preferences being senior to the rights of holders of common stock.


During January 2017 to March, 2017, 48 shareholders of the Company, who previously acquired shares of the Company’s common stock, par value of $0.001 per share (The “SMSA Crane Shares”), in a private placement with the Company, at a price of $3.31 per share, entered into an share exchange agreement with Coqui. The 48 investors agreed to exchange their SMSA Crane Shares for an equal value of shares of Coqui’s common stock, par value $0.1 per share (the “Coqui Shares”), and Coqui agreed to proceed with the proposed share exchange.  As a result, 1,663,443 SMSA Crane Shares outstanding held by these 48 shareholders and 151,300 outstanding warrants held by Pariter, the placement agent, were exchanged for Coqui Shares and Coqui Warrants and the Company cancelled these SMSA Crane Shares and warrants.


On May 16, 2017, the Board of Directors approved the issuance of 47,490 shares of its common shares to Coquí, based on the private placement share price of $3.31 in satisfaction for the total debt owed to Coqui of $157,194.


On June 26, 2017, our former controlling shareholder, Coqui Radio Pharmaceuticals, Corp. (“Coqui”), sold 9,947,490 shares of common stock to Irwin Eskanos for a purchase price of $250,000. See Note B - Changes of Control.


There were no preferred shares issued and outstanding at September 30, 2017 and December 31, 2016. There were 10,047,495 shares and 11,663,448 shares of common stock issued and outstanding as of September 30, 2017 and December 31, 2016, respectively.


Stock Warrants


The following table summarizes all warrant activity:


 

 

Warrants

 

 

Weighted

Average

Exercise

Price

 

 

Weighted Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

 

151,300

 

 

$

3.31

 

 

 

2.25

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(151,300

 

$

3.31

 

 

 

 

 

 

 

Outstanding at September 30, 2017

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2017

 

 

 

 

 

 

 

 

 

 

 

 


Note L- Subsequent Events


In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.




8



 


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.


Forward-Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

 

Overview

 

Our business plan is to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. We are not restricting our potential target companies to any specific business, industry or geographical location. No assurances can be given that we will be successful in locating or negotiating with any target company.


On June 26, 2017, our former controlling shareholder, Coqui Radio Pharmaceuticals, Corp. (“Coqui”), sold 9,947,490 shares of common stock to Irwin Eskanos in a private transaction. Concurrently with this sale of controlling interest, our board of directors appointed Mr. Eskanos as our new sole Director, President, Secretary, Treasurer, CEO, and CFO, and accepted the resignation of Carmen I. Bigles, our former sole officer and director. Also, concurrently with the sale of controlling interest, Coqui agreed pay in full, and indemnify us for, our outstanding liabilities as of the date of the sale.


Our continued existence is dependent upon our ability to generate new financing or sufficient cash flows to continue our reporting obligations to the Securities and Exchange Commission on a timely basis. We can provide no assurance that we will achieve a business combination through the acquisition of, or merger with, an existing company. We currently do not have any firm arrangements for financing and we may not be able to obtain financing when required, in the amounts necessary to execute on our plans in full, or on terms which are economically feasible.


Expected Changes In Number of Employees, Plant, and Equipment

 

We do not currently plan to purchase specific additional physical plant and significant equipment within the immediate future. We do not currently have specific plans to change the number of our employees during the next twelve months.


Results of Operations

 

For the three months ended September 30, 2017 and 2016


Revenue


The Company had no revenue for the three months ended September 30, 2017 and 2016 respectively.


Operating Expenses


The following table presents our total operating expenses for the three months ended September 30, 2017 and 2016:


 

 

Three months ended

September 30,

 

 

 

2017

 

 

2016

 

Professional fees

 

$

8,845

 

 

$

717

 

Other general and administrative costs

 

 

3,321

 

 

 

158

 

Operating expenses

 

$

12,166

 

 

$

875

 




9



 


Operating expenses consist mostly of the maintenance fee of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission. The increase in other general and administrative costs in 2017 was mainly due to the increase in professional fees in 2017.


Net loss per share for the three months ended September 30, 2017 and 2016 was approximately $(0.00) and $(0.00), respectively based on the weighted-average shares issued and outstanding.


It is anticipated that future operating expenses will increase as the Company complies with its periodic reporting requirements and effects a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.

 

For the nine months ended September 30, 2017 and 2016


Revenue


The Company had no revenue for the nine months ended September 30, 2017 and 2016 respectively.


Operating Expenses


The following table presents our total operating expenses for the nine months ended September 30, 2017 and 2016:


 

 

Nine months ended

September 30,

 

 

 

2017

 

 

2016

 

Professional fees

 

$

45,845

 

 

$

1,240

 

Other general and administrative costs

 

 

9,169

 

 

 

461

 

Operating expenses

 

$

55,014

 

 

$

1,701

 


Operating expenses consist mostly of the maintenance fee of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission. The increase in other general and administrative costs in 2017 was mainly due to the increase in professional fees in 2017.


Net loss per share for the nine months ended September 30, 2017 and 2016 was approximately $(0.01) and $(0.00), respectively based on the weighted-average shares issued and outstanding.


It is anticipated that future operating expenses will increase as the Company complies with its periodic reporting requirements and effects a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.


Liquidity and Capital Resources

 

Since its inception, the Company has financed its cash requirements from the sale of common stock and advances from related parties. Uses of funds have included activities to establish our business, professional fees and other general and administrative expenses.

 

We believe the Company will need additional resources to implement its strategic objectives in upcoming quarters. Due to our lack of operating history, however, our auditors have stated their opinion that there currently exists substantial doubt about our ability to continue as a going concern. As of September 30, 2017, the Company has an accumulated deficit of approximately $361,000. The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months.

 

The ability of the Company to continue as a going concern is dependent upon, among other things, obtaining additional financing to continue its filings with the Securities and Exchange Commission in 2017. In response to this and other potential problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.




10



 


The following table provides detailed information about our net cash flow for years presented in this Report.


Cash Flow


 

 

Nine months ended

September 30,

 

 

 

2017

 

 

2016

 

Net cash used in operating activities

 

$

(5,366

)

 

$

(2,579

)

Net cash provided by investing activities

 

 

 

 

 

 

Net cash provided by financing activities

 

 

35,235

 

 

 

2,579

 

Net cash inflow (outflow)

 

$

29,869

 

 

$

 


Operating Activities


Cash used in operating activities for the nine months ended September 30, 2017, consisted of net loss as well as the effect of changes in working capital. The increase in cash used in operating activities of approximately $3,000 was mainly due to the increase in net loss in 2017 of approximately $53,000 and decrease in accounts payable of approximately $50,000.


Investing Activities


Net cash provided by our investing activities for the nine months ended September 30, 2017 and 2016 was $0.


Financing Activities


Net cash provided by our financing activities for the nine months ended September 30, 2017, as compared to 2016 was increased by of approximately $33,000. This increase was due to increase in advance from shareholder of approximately $39,000 offset by the repayment to a related party of approximately $5,000 and decrease in advance from a former shareholder of approximately $1,000.


On June 27, 2017, the Parent paid off all liabilities of approximately $130,000 directly to all creditors. The Parent agreed to forgive all debts due to Parent by the Company and we recorded this contribution of $130,000 under additional paid in capital and disclosed as non-cash items at the Condensed Statements of Cash Flows.


Pending our completion of a future potential business combination, we are not conducting any business activities. Our only operating activities are to comply with Securities and Exchange Commission reporting requirements and to seek to complete a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation.

  

Off Balance Sheet Arrangements

 

As of September 30, 2017, there were no off balance sheet arrangements.

 

Critical Accounting Policies

 

In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We do not believe that any accounting policies currently fit this definition.

 

Recently Issued Accounting Pronouncements

 

Our management has considered all recent accounting pronouncements issued since the last audit of our financial statements. Our management believes that these recent pronouncements will not have a material effect on our financial statements.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.


A smaller reporting company is not required to provide the information required by this Item.




11



 


ITEM 4. CONTROLS AND PROCEDURES.


We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2017. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, Irwin Eskanos. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2017, our disclosure controls and procedures are not effective. There have been no changes in our internal controls over financial reporting during the quarter ended September 30, 2017.


Management determined that the material weaknesses that resulted in controls being ineffective are primarily due to lack of resources and number of employees. Material weaknesses exist in the segregation of duties required for effective controls and various reconciliation and control procedures not regularly performed due to the lack of staff and resources.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Limitations on the Effectiveness of Internal Controls

 

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error.   Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the internal control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.






12



 


PART II—OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS.


None.


ITEM 1A. RISK FACTORS.


A smaller reporting company is not required to provide the information required by this Item.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES OR USE OF PROCEEDS.


None.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES.


None.


ITEM 4. MINE SAFETY DISCLOSURES.


Not applicable.


ITEM 5. OTHER INFORMATION.


None.


ITEM 6. EXHIBITS.


Exhibit

Number

 

Description of Exhibit

31.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

 

Materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 formatted in Extensible Business Reporting Language (XBRL)







13



 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

 

SMSA Crane Acquisition Corp.

 

 

 

 

 

 

 

 

Date: November 13, 2017

 

By: 

/s/ Irwin Eskanos

 

 

Name:

Irwin Eskanos

 

 

Title:

Chief Executive Officer,

 

 

 

Chief Financial Officer, and Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 










14


EX-31.1 2 sscr_ex31z1.htm CERTIFICATIONS Certification

EXHIBIT 31.1


CERTIFICATIONS


I, Irwin Eskanos, certify that;

 

1.

 

I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2017 of SMSA Crane Acquisition Corp. (the “registrant”);

 

2.

 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

 

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

 

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

 

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

 

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

 

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2017

 

/s/ Irwin Eskanos

By: Irwin Eskanos

Title: Chief Executive Officer




EX-31.2 3 sscr_ex31z2.htm CERTIFICATIONS Certification

EXHIBIT 31.2


CERTIFICATIONS


I, Irwin Eskanos, certify that;

 

1.

 

I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2017 of SMSA Crane Acquisition Corp. (the “registrant”);

 

2.

 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

 

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

 

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

 

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

 

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

 

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2017

 

/s/ Irwin Eskanos

By: Irwin Eskanos

Title: Chief Financial Officer




EX-32.1 4 sscr_ex32z1.htm CERTIFICATION Certification

EXHIBIT 32.1


CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly Report of SMSA Crane Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2017 filed with the Securities and Exchange Commission (the “Report”), I, Irwin Eskanos, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1.

The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and


2.

The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.



By:

/s/ Irwin Eskanos

Name:

Irwin Eskanos

Title:

Principal Executive Officer, Principal Financial Officer and Director

Date:

November 13, 2017


This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



EX-101.INS 5 sscr-20170930.xml XBRL INSTANCE FILE 0001473287 2016-12-31 0001473287 2016-01-01 2016-12-31 0001473287 sscr:CoquiRadioPharmaceuticalsCorpMember 2013-08-01 2013-08-31 0001473287 sscr:CoquiRadioPharmaceuticalsCorpMember 2013-08-01 2013-10-31 0001473287 sscr:CoquiRadioPharmaceuticalsCorpMember 2013-10-01 2013-10-31 0001473287 2017-11-06 0001473287 2015-12-31 0001473287 2015-01-01 2015-12-31 0001473287 2016-09-30 0001473287 2016-01-01 2016-09-30 0001473287 sscr:CoquiRadioPharmaceuticalsCorpMember 2017-03-31 0001473287 2017-05-16 0001473287 2017-05-01 2017-05-16 0001473287 2017-01-01 2017-09-30 0001473287 2017-09-30 0001473287 2017-07-01 2017-09-30 0001473287 2016-07-01 2016-09-30 0001473287 2017-06-26 2017-06-27 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 0.001 0.001 10000000 10000000 0.001 0.1 0.001 100000000 100000000 0 0 11663448 10047495 0 0 29869 10047495 11663448 10047495 9500000 400000 280000 -244000 -12000 0 151300 151300 3.31 3.31 P2Y2M30D P3Y3M4D 3.31 3.31 47490 10-Q false 2017-09-30 SMSA CRANE ACQUISITION CORP. 0001473287 --12-31 2017 Q3 Smaller Reporting Company 1663443 <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note A - Basis of presentation, Background and Description of Business</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; border-left-width: 0pc; border-left-color: Black"><b>Basis of presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The accompanying unaudited condensed financial statements of SMSA Crane Acquisition Corp. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited financial statements for the year ended December 31, 2016, included in our Annual Report on Form 10-K for the year ended December 31, 2016.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine month periods have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms &#34;Company&#34;, &#34;we&#34;, &#34;us&#34; or &#34;our&#34; mean SMSA Crane Acquisition Corp.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; border-left-width: 0pc; border-left-color: Black"><b>Background and Description of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">SMSA Crane Acquisition Corp. was organized on September 9, 2009 as a Nevada corporation to effect the reincorporation of Senior Management Services of Crane, Inc., a Texas corporation, mandated by the plan of reorganization discussed below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company's emergence from Chapter 11 of Title 11 of the United States Code on August 1, 2007 caused a change in majority ownership and voting control - that is, loss of control by the then-existing stockholders, a court-approved reorganization, and a reliable measure of the entity's fair value - resulting in a fresh start, creating, in substance, a new reporting entity. Accordingly, the Company, post-bankruptcy, had no significant assets, liabilities or operating activities. Therefore, the Company, as a new reporting entity, qualified as a shell company as defined in Rule 405 under the Securities Act of 1933, and Rule 12b-2 under the Securities Exchange Act of 1934. The Company's Plan of Reorganization (the &#34;Plan&#34;) was confirmed by the United States Bankruptcy Court, Northern District of Texas &#8211; Dallas Division on August 1, 2007 and became effective on August 10, 2007.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">On August 29, 2013, Coqu&#237; Radio Pharmaceuticals, Corp. (&#34;Coqu&#237;&#34;) closed a transaction through which Coqu&#237; purchased 9,500,000 outstanding shares of common stock and agreed to purchase an additional 400,000 outstanding shares of common stock of the Company from existing shareholders in a private transaction in exchange for $280,000. The additional 400,000 shares were subsequently acquired on October 24, 2013 and Coqu&#237; became the majority controlling stockholder of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. The Company is not restricting its potential target companies to any specific business, industry or geographical location. No assurances can be given that the Company will be successful in locating or negotiating with any target company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note B - Change of Control</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Coqui the principal shareholder of the Company entered the Stock Purchase Agreement, effective as of the 26th day of June, 2017, with Irwin Eskanos (&#8220;Buyer&#8221;). Coqui agreed to sell to the Buyer, and the Buyer agreed to purchase from Coqui, a total of 9,947,490 shares of common stock of the Company for a total purchase price of $250,000. &#160;These purchased shares represented approximately 99.00% of the Company&#8217;s issued and outstanding shares of Common Stock. Also, concurrently with the sale of controlling interest, Coqui paid all outstanding liabilities of the Company as of the date of this sale. As a result, Coqui paid $130,000 of the Company&#8217;s outstanding accounts payable through the attorney&#8217;s escrow accounts and agreed to forgive all of its debts at the closing of this transaction. The Company recorded Coqui&#8217;s forgiveness of debt of $130,000 under Additional paid in capital, for the three months and nine months ended September 30, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">On June 26, 2017, the board of directors appointed Irwin Eskanos as our new sole Director, President, Secretary, Treasurer, CEO, and CFO. Following these appointments, the board accepted the resignation of Carmen I. Bigles as our former sole officer and director.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note C &#8211; Going Concern</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. Our net losses incurred for the nine months ended September 30, 2017 and 2016, amounted to approximately $55,000 and $1,700, respectively, and working capital (deficits) was approximately $(12,000) and $(244,000), respectively, at September 30, 2017 and December 31, 2016. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pc">Note D - Summary of Significant Accounting Policies and Recent Accounting Pronouncements</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Cash and cash equivalents</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Income taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company files income tax returns in the United States of America and various states, as appropriate and applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company has adopted the provisions of ASC 740-10 &#34;Accounting for Uncertain Income Tax Positions&#34;. The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a &#34;more-likely-than-not&#34; probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Income (Loss) per share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position at the calculation date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">As of September 30, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. At September 30, 2017 there were 0 outstanding common stock warrants, which could dilute future earnings per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recently Adopted Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-15 &#8211; &#8220;Presentation of Financial Statements&#8212;Going Concern&#8212;Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;).&#8221; In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity&#8217;s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The updated accounting guidance was effective for the Company on December 31, 2016. We have implemented this new accounting standard and we will update our liquidity disclosures as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently-Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory (&#34;ASU 2016-16&#34;), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its financial statements.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note E - Fair Value of Financial Instruments and fair value measurements</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The carrying amount of cash, accounts payable and accrued expenses and due to stockholder, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The carrying amount of due to the shareholder and accrued liabilities, as applicable, approximates fair value due to the short-term nature of these items. The fair value of the related party notes payable cannot be determined because of the Company's affiliation with the parties with whom the agreements exist. The carrying amount approximates its fair value at September 30, 2017 and December 31, 2016. The use of different assumptions or methodologies may have a material effect on the estimates of fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">ASC Topic 820, &#34;Fair Value Measurements and Disclosures,&#34; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#34;Financial Instruments,&#34; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%; padding-right: 1pt; text-align: justify"><font style="font-family: Symbol">&#183;</font></td> <td style="width: 9%; padding-right: 1pt; text-align: justify">Level 1:</td> <td style="width: 87%; padding-right: 1pt; text-align: justify">Observable inputs such as quoted prices in active markets;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 1pt; text-align: justify"><font style="font-family: Symbol">&#183;</font></td> <td style="padding-right: 1pt; text-align: justify">Level 2:</td> <td style="padding-right: 1pt; text-align: justify">Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 1pt; text-align: justify"><font style="font-family: Symbol">&#183;</font></td> <td style="padding-right: 1pt; text-align: justify">Level 3:</td> <td style="padding-right: 1pt; text-align: justify">Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note G - Due to Former Shareholder</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">As of September 30, 2017 and December 31, 2016, the Company owes $0 and $155,670, respectively, to Coqu&#237;, the former principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note H - Due to Related Party</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">As of September 30, 2017 and December 31, 2016, the Company owes $0 and $5,405, respectively, to Ms. Carmen I. Bigles, our former Chief Executive Officer and sole Director of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note I - Concentration of Credit Risk</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">At times cash deposited with financial institutions may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2017.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note J - Contingencies</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company was contemplating a possible merger by the Company and Coqu&#237;. The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. No assurances can be given that the Company will be successful in pursuing a business combination in the near future or at all.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note K- Stockholders' Deficit</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Pursuant to our Articles of Incorporation, our board has the authority, without further stockholder approval, to provide for the issuance of up to 10,000,000 shares of our preferred stock in one or more series and to determine the dividend rights, conversion rights, voting rights, rights in terms of redemption, liquidation preferences, the number of shares constituting any such series and the designation of such series. Our board has the power to afford preferences, powers and rights (including voting rights) to the holders of any preferred stock preferences, such rights and preferences being senior to the rights of holders of common stock.</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">During January 2017 to March, 2017, 48 shareholders of the Company, who previously acquired shares of the Company&#8217;s common stock, par value of $0.001 per share (The &#8220;SMSA Crane Shares&#8221;), in a private placement with the Company, at a price of $3.31 per share, entered into an share exchange agreement with Coqui. The 48 investors agreed to exchange their SMSA Crane Shares for an equal value of shares of Coqui&#8217;s common stock, par value $0.1 per share (the &#8220;Coqui Shares&#8221;), and Coqui agreed to proceed with the proposed share exchange. As a result, 1,663,443 SMSA Crane Shares outstanding held by these 48 shareholders and 151,300 outstanding warrants held by Pariter, the placement agent, were exchanged for Coqui Shares and Coqui Warrants and the Company cancelled these SMSA Crane Shares and warrants.</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">On May 16, 2017, the Board of Directors approved the issuance of 47,490 shares of its common shares to Coqu&#237;, based on the private placement share price of $3.31 in satisfaction for the total debt owed to Coqui of $157,194.</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">On June 26, 2017, our former controlling shareholder, Coqui Radio Pharmaceuticals, Corp. (&#8220;Coqui&#8221;), sold 9,947,490 shares of common stock to Irwin Eskanos for a purchase price of $250,000. See Note B - Changes of Control.</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">There were no preferred shares issued and outstanding at September 30, 2017 and December 31, 2016. There were 10,047,495 shares and 11,663,448 shares of common stock issued and outstanding as of September 30, 2017 and December 31, 2016, respectively.</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Stock Warrants</b></p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The following table summarizes all warrant activity:</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: center"><font style="font-size: 8pt"><b>Warrants</b></font></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Weighted</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Average</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Exercise</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Price</b></p></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Weighted Average</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Remaining</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Contractual</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Life (Years)</b></p></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Aggregate</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Intrinsic</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Value</b></p></td> <td nowrap="nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 44%; padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Outstanding at December 31, 2016</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 11%; padding-right: 1pt; text-align: right">151,300</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">$</td> <td style="width: 10%; padding-right: 1pt; text-align: right">3.31</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 12%; padding-right: 1pt; text-align: right">2.25</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 11%; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">Granted</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 1pt; text-align: justify">Exercised</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">Cancelled</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">(151,300</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">)&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">$</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">3.31</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Outstanding at September 30, 2017</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Exercisable at September 30, 2017</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> </table> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: bold 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note L- Subsequent Events</p> <p style="font: 10pt/8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Cash and cash equivalents</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Income taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company files income tax returns in the United States of America and various states, as appropriate and applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">The Company has adopted the provisions of ASC 740-10 &#34;Accounting for Uncertain Income Tax Positions&#34;. The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a &#34;more-likely-than-not&#34; probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>Income (Loss) per share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position at the calculation date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">As of September 30, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. At September 30, 2017 there were 0 outstanding common stock warrants, which could dilute future earnings per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify"><b>&#160;</b></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recently Adopted Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-15 &#8211; &#8220;Presentation of Financial Statements&#8212;Going Concern&#8212;Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;).&#8221; In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity&#8217;s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The updated accounting guidance was effective for the Company on December 31, 2016. We have implemented this new accounting standard and we will update our liquidity disclosures as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently-Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory (&#34;ASU 2016-16&#34;), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: center"><font style="font-size: 8pt"><b>Warrants</b></font></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Weighted</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Average</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Exercise</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Price</b></p></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Weighted Average</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Remaining</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Contractual</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Life (Years)</b></p></td> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Aggregate</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Intrinsic</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: center"><b>Value</b></p></td> <td nowrap="nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: right">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#160;</td> <td colspan="2" style="padding-right: 1pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 1pt; text-align: justify">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 44%; padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Outstanding at December 31, 2016</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 11%; padding-right: 1pt; text-align: right">151,300</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">$</td> <td style="width: 10%; padding-right: 1pt; text-align: right">3.31</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 12%; padding-right: 1pt; text-align: right">2.25</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="width: 1%; padding-right: 1pt">&#160;</td> <td style="width: 11%; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="width: 1%; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">Granted</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 1pt; text-align: justify">Exercised</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; text-align: justify">Cancelled</td> <td style="padding-right: 1pt; text-align: justify">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">(151,300</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">)&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">$</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">3.31</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td> <td style="padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 1pt solid; padding-right: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Outstanding at September 30, 2017</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">Exercisable at September 30, 2017</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc; text-align: justify">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt">&#160;</td> <td style="border-bottom: Black 2.25pt double; padding-right: 1pt; text-align: right">&#8212;</td> <td nowrap="nowrap" style="border-bottom: white 2.25pt double; padding-right: 1pt; padding-bottom: 0.25pc">&#160;</td></tr> </table> <p style="margin: 0pt"></p> 9947490 250000 .9900 130000 130000 157194 151300 3.31 244347 42035 5405 39115 0 29869 11664 10048 49546 338357 -305557 -360571 -244347 -12166 0 29869 155670 83272 2920 11663448 10245213 10047495 11663448 -0.00 -0.01 -0.00 -0.00 -1701 -55014 -12166 -875 -1701 -55014 -12166 -875 1701 55014 12166 875 461 9169 3321 158 1240 45845 8845 717 -878 49648 -5405 29869 1663 157195 39115 2579 1525 0 <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pc">Note F - Due to Shareholder</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">As of September 30, 2017 and December 31, 2016, the Company owes $39,115 and $0, respectively, to Mr. Irwin Eskanos, the principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1pt 0 0; text-align: justify">&#160;</p> -2579 -5366 2579 35235 EX-101.SCH 6 sscr-20170930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Basis of Presentation, Background and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Change of Control link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Fair Value of Financial Instruments and fair value measurements link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Due to Shareholder link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Due to Former Shareholder link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Due to Related Party link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Basis of presentation, Background and Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Change of Control (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Due to Shareholder (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Due to Former Shareholder (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Due to Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stockholders' Deficit (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders' Deficit (Schedule of Warrant Activity) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 sscr-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 sscr-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 sscr-20170930_lab.xml XBRL LABEL FILE Related Party Transactions, by Related Party [Axis] Coqui Radio Pharmaceuticals Corp [Member] Document and Entity Information [Abstract] Document Type Amendment Flag Document Period End Date Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Filer Category Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] ASSETS Current Assets Cash - attorney escrow account Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses Due to shareholder Due to former shareholder Due to related party Total Liabilities Contingencies (Note J) Stockholders' Deficit Preferred stock - $0.001 par value, 10,000,000 shares authorized. None issued and outstanding Common stock - $0.001 par value, 100,000,000 shares authorized. 10,047,495 shares and 11,663,448 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively Additional paid-in capital Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred stock, par value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating expenses Professional fees Other general and administrative expenses Total operating expenses Loss from operations Provision for income taxes Net Loss Loss per weighted-average share of common stock outstanding, computed on net loss - basic and fully diluted Weighted-average number of shares of common stock outstanding - basic and fully diluted Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net loss for the period Adjustments to reconcile net loss to net cash used in operating activities Changes in operating working capital items: Accounts payable Due to Parent Due to related party Net Cash Used in Operating Activities Cash Flows from Investing Activities: Net Cash Provided by Investing Activities Cash Flows from Financing Activities: Repayment to a related party Advance from shareholder Advance from a former shareholder Net Cash Provided by Financing Activities Increase in Cash Cash at beginning of period Cash at end of period Supplemental Disclosure of Interest and Income Taxes Paid: Interest paid during the period Income taxes paid during the period Supplemental Disclosure of Non-cash Flow Investing and Financing Activities: Cancellation of shares Shares issued for debt Forgiveness of debt Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation, Background and Description of Business Reorganizations [Abstract] Change of Control [Abstract] Change of Control Going Concern [Abstract] Going Concern Accounting Policies [Abstract] Summary of Significant Accounting Policies and Recent Accounting Pronouncements Fair Value Disclosures [Abstract] Fair Value of Financial Instruments and fair value measurements Related Party Transactions [Abstract] Due to Shareholder Due to Related Parties, Current [Abstract] Due to Former Shareholder Due To Related Party Due to Related Party Risks and Uncertainties [Abstract] Concentration of Credit Risk Commitments and Contingencies Disclosure [Abstract] Contingencies Stockholders' Equity Note [Abstract] Stockholders' Deficit Subsequent Events [Abstract] Subsequent Events Use of Estimates Cash and cash equivalents Income taxes Income (Loss) per share Recently Adopted Accounting Pronouncements Recent Accounting Pronouncements Schedule of Warrant Activity Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related Party [Axis] Shares of common stock issued for cash Proceeds from issuance of private placement Common stock issued for cash, price per share Change Of Control Details Number of shares sold to buyer of company Total purchase price of shares sold to buyer of company Percentage of outstanding shares sold to buyer in purchase of company Accounts payable paid by previous owner of company Forgiveness of debt recorded by company Net Loss Working capital deficits Outstanding stock warrants, options or convertible securities which could be considered as dilutive for purposes of the loss per share calculation Outstanding common stock warrants which could dilute future earnings per share Proceeds from sale of common stock Due To Related Party Details Due to Related Party Schedule of Stock by Class [Table] Class of Stock [Line Items] Share price Shares of common stock exchanged and cancelled Warrants cancelled Number of shares cancelled Debt exchanged for stock Debt exchanged for stock, shares Warrants Outstanding Granted Exercised Cancelled Outstanding Exercisable Weighted Average Exercise Price Outstanding Granted Exercised Cancelled Outstanding Exercisable Aggregate Intrinsic Value Outstanding Granted Exercised Cancelled Outstanding Exercisable Weighted Average Remaining Contractual Life (Years) Granted Outstanding Exercisable Carolyn C. Shelton [Member] Coqui Radio Pharmaceuticals, Corp. ("Coqui") Document and Entity Information [Abstract] The entire disclosure for amounts due to related parties. Going Concern [Abstract] Halter Financial Group, Inc. [Member] Number of shares cancelled during the period. Pariter Securities, LLC ("Pariter") [Member] Recently Adopted Accounting Pronouncements policy. Numbe of shares of stock exchanged and cancelled during the period. Warrant Activity Aggregate Intrinsic Value [Abstract] Aggregate intrinsic value of exercisable warrants. Aggregate intrinsic value of warrants exercised during the period. Aggregate intrinsic value of warrants granted during the period. Aggregate intrinsic value of outstanding warrants. Weighted average exercise price of exercisable warrants. Weighted average exercise price of warrants exercised during the period. Weighted average exercise price of warrants granted during the period. The weighted average exercise price of warrants outstanding. Number of exercisable warrants. Number of warrants exercised during the period. Number of warrants granted during the period. Number of warrants outstanding. Warrant Activity Warrants Outstanding [Abstract] Warrant Activity Weighted Average Exercise Price [Abstract] Warrant Activity Weighted Average Remaining Contractual Life [Abstract] Weighted average remaining contractual life of exercisable warrants. Weighted average remaining contractual life of warrants granted during the period. Weighted average remaining contractual life of warrants outstanding. Number of warrants outstanding which could dilute the future computation of earnings per share (EPS) or earnings per unit (EPU). Working capital deficit. Cancellation of shares. The entire disclosure for amounts due to a former shareholder. The entire disclosure relating to change of control. Number of shares sold to buyer of company. Total purchase price of shares sold to buyer of company. Percentage of outstanding shares sold to buyer in purchase of company. Accounts payable paid by previous owner of company. Number of warrants cancelled during the period. Weighted average exercise price of warrants cancelled during the period. Aggregate intrinsic value of warrants cancelled during the period. The cash inflow from a long-term borrowing made from former related parties. Assets Due to Related Parties, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Due to Stockholder [Text Block] Stockholders' Equity Note Disclosure [Text Block] Income Tax, Policy [Policy Text Block] WorkingCapitalDeficits Warrant Activity Warrants Outstanding Warrant Activity Warrants Exercisable Warrant Activity Outstanding Weighted Average Exercise Price Warrant Activity Granted Weighted Average Exercise Price Warrant Activity Exercised Weighted Average Exercise Price Warrant Activity Exercisable Weighted Average Exercise Price Warrant Activity Aggregate Intrinsic Value Outstanding Warrant Activity Aggregate Intrinsic Value Granted Warrant Activity Aggregate Intrinsic Value Exercised WarrantActivityAggregateIntrinsicValueCancelled Warrant Activity Aggregate Intrinsic Value Exercisable Warrant Activity Weighted Average Remaining Contractual Life Granted EX-101.PRE 10 sscr-20170930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2017
Nov. 06, 2017
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2017  
Entity Registrant Name SMSA CRANE ACQUISITION CORP.  
Entity Central Index Key 0001473287  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   10,047,495
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current Assets    
Cash - attorney escrow account $ 29,869
Total Assets 29,869 0
Current Liabilities    
Accounts payable and accrued expenses 2,920 83,272
Due to shareholder 39,115
Due to former shareholder 155,670
Due to related party 5,405
Total Liabilities 42,035 244,347
Stockholders' Deficit    
Preferred stock - $0.001 par value, 10,000,000 shares authorized. None issued and outstanding
Common stock - $0.001 par value, 100,000,000 shares authorized. 10,047,495 shares and 11,663,448 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively 10,048 11,664
Additional paid-in capital 338,357 49,546
Accumulated deficit (360,571) (305,557)
Total Stockholders' Deficit (12,166) (244,347)
Total Liabilities and Stockholders' Deficit $ 29,869 $ 0
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2017
Dec. 31, 2016
Statement of Financial Position [Abstract]    
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value per share $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 10,047,495 11,663,448
Common stock, shares outstanding 10,047,495 11,663,448
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues
Operating expenses        
Professional fees 8,845 717 45,845 1,240
Other general and administrative expenses 3,321 158 9,169 461
Total operating expenses 12,166 875 55,014 1,701
Loss from operations (12,166) (875) (55,014) (1,701)
Provision for income taxes
Net Loss $ (12,166) $ (875) $ (55,014) $ (1,701)
Loss per weighted-average share of common stock outstanding, computed on net loss - basic and fully diluted $ (0.00) $ (0.00) $ (0.01) $ (0.00)
Weighted-average number of shares of common stock outstanding - basic and fully diluted 10,047,495 11,663,448 10,245,213 11,663,448
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statement of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash Flows from Operating Activities:    
Net loss for the period $ (55,014) $ (1,701)
Changes in operating working capital items:    
Accounts payable 49,648 (878)
Net Cash Used in Operating Activities (5,366) (2,579)
Cash Flows from Investing Activities:    
Net Cash Provided by Investing Activities
Cash Flows from Financing Activities:    
Repayment to a related party (5,405)
Advance from shareholder 39,115
Advance from a former shareholder 1,525 2,579
Net Cash Provided by Financing Activities 35,235 2,579
Increase in Cash 29,869
Cash at beginning of period
Cash at end of period 29,869
Supplemental Disclosure of Interest and Income Taxes Paid:    
Interest paid during the period
Income taxes paid during the period
Supplemental Disclosure of Non-cash Flow Investing and Financing Activities:    
Cancellation of shares 1,663
Shares issued for debt 157,195
Forgiveness of debt $ 130,000
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Basis of Presentation, Background and Description of Business
9 Months Ended
Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation, Background and Description of Business

Note A - Basis of presentation, Background and Description of Business

 

Basis of presentation

 

The accompanying unaudited condensed financial statements of SMSA Crane Acquisition Corp. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited financial statements for the year ended December 31, 2016, included in our Annual Report on Form 10-K for the year ended December 31, 2016.

 

In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine month periods have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms "Company", "we", "us" or "our" mean SMSA Crane Acquisition Corp.

 

Background and Description of Business

 

SMSA Crane Acquisition Corp. was organized on September 9, 2009 as a Nevada corporation to effect the reincorporation of Senior Management Services of Crane, Inc., a Texas corporation, mandated by the plan of reorganization discussed below.

 

The Company's emergence from Chapter 11 of Title 11 of the United States Code on August 1, 2007 caused a change in majority ownership and voting control - that is, loss of control by the then-existing stockholders, a court-approved reorganization, and a reliable measure of the entity's fair value - resulting in a fresh start, creating, in substance, a new reporting entity. Accordingly, the Company, post-bankruptcy, had no significant assets, liabilities or operating activities. Therefore, the Company, as a new reporting entity, qualified as a shell company as defined in Rule 405 under the Securities Act of 1933, and Rule 12b-2 under the Securities Exchange Act of 1934. The Company's Plan of Reorganization (the "Plan") was confirmed by the United States Bankruptcy Court, Northern District of Texas – Dallas Division on August 1, 2007 and became effective on August 10, 2007.

 

On August 29, 2013, Coquí Radio Pharmaceuticals, Corp. ("Coquí") closed a transaction through which Coquí purchased 9,500,000 outstanding shares of common stock and agreed to purchase an additional 400,000 outstanding shares of common stock of the Company from existing shareholders in a private transaction in exchange for $280,000. The additional 400,000 shares were subsequently acquired on October 24, 2013 and Coquí became the majority controlling stockholder of the Company.

 

The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. The Company is not restricting its potential target companies to any specific business, industry or geographical location. No assurances can be given that the Company will be successful in locating or negotiating with any target company.

 

XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Change of Control
9 Months Ended
Sep. 30, 2017
Change of Control [Abstract]  
Change of Control

Note B - Change of Control

 

Coqui the principal shareholder of the Company entered the Stock Purchase Agreement, effective as of the 26th day of June, 2017, with Irwin Eskanos (“Buyer”). Coqui agreed to sell to the Buyer, and the Buyer agreed to purchase from Coqui, a total of 9,947,490 shares of common stock of the Company for a total purchase price of $250,000.  These purchased shares represented approximately 99.00% of the Company’s issued and outstanding shares of Common Stock. Also, concurrently with the sale of controlling interest, Coqui paid all outstanding liabilities of the Company as of the date of this sale. As a result, Coqui paid $130,000 of the Company’s outstanding accounts payable through the attorney’s escrow accounts and agreed to forgive all of its debts at the closing of this transaction. The Company recorded Coqui’s forgiveness of debt of $130,000 under Additional paid in capital, for the three months and nine months ended September 30, 2017.

 

On June 26, 2017, the board of directors appointed Irwin Eskanos as our new sole Director, President, Secretary, Treasurer, CEO, and CFO. Following these appointments, the board accepted the resignation of Carmen I. Bigles as our former sole officer and director.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Going Concern
9 Months Ended
Sep. 30, 2017
Going Concern [Abstract]  
Going Concern

Note C – Going Concern

 

We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. Our net losses incurred for the nine months ended September 30, 2017 and 2016, amounted to approximately $55,000 and $1,700, respectively, and working capital (deficits) was approximately $(12,000) and $(244,000), respectively, at September 30, 2017 and December 31, 2016. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies and Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2017
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies and Recent Accounting Pronouncements

Note D - Summary of Significant Accounting Policies and Recent Accounting Pronouncements

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.

 

Cash and cash equivalents

 

The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.

 

Income taxes

 

The Company files income tax returns in the United States of America and various states, as appropriate and applicable.

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Company has adopted the provisions of ASC 740-10 "Accounting for Uncertain Income Tax Positions". The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a "more-likely-than-not" probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.

 

Income (Loss) per share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.

 

Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants).

 

Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position at the calculation date.

 

As of September 30, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. At September 30, 2017 there were 0 outstanding common stock warrants, which could dilute future earnings per share.

 

Recently Adopted Accounting Pronouncements

 

Going Concern

 

ASU 2014-15 – “Presentation of Financial Statements—Going Concern—Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”).” In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The updated accounting guidance was effective for the Company on December 31, 2016. We have implemented this new accounting standard and we will update our liquidity disclosures as necessary.

 

Recent Accounting Pronouncements

 

Recently-Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 

Income Taxes

 

In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory ("ASU 2016-16"), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its financial statements.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value of Financial Instruments and fair value measurements
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments and fair value measurements

Note E - Fair Value of Financial Instruments and fair value measurements

 

The carrying amount of cash, accounts payable and accrued expenses and due to stockholder, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.

 

The carrying amount of due to the shareholder and accrued liabilities, as applicable, approximates fair value due to the short-term nature of these items. The fair value of the related party notes payable cannot be determined because of the Company's affiliation with the parties with whom the agreements exist. The carrying amount approximates its fair value at September 30, 2017 and December 31, 2016. The use of different assumptions or methodologies may have a material effect on the estimates of fair values.

 

ASC Topic 820, "Fair Value Measurements and Disclosures," requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, "Financial Instruments," defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

· Level 1: Observable inputs such as quoted prices in active markets;
     
· Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
     
· Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Shareholder
9 Months Ended
Sep. 30, 2017
Related Party Transactions [Abstract]  
Due to Shareholder

Note F - Due to Shareholder

 

As of September 30, 2017 and December 31, 2016, the Company owes $39,115 and $0, respectively, to Mr. Irwin Eskanos, the principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Former Shareholder
9 Months Ended
Sep. 30, 2017
Due to Related Parties, Current [Abstract]  
Due to Former Shareholder

Note G - Due to Former Shareholder

 

As of September 30, 2017 and December 31, 2016, the Company owes $0 and $155,670, respectively, to Coquí, the former principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Related Party
9 Months Ended
Sep. 30, 2017
Due To Related Party  
Due to Related Party

Note H - Due to Related Party

 

As of September 30, 2017 and December 31, 2016, the Company owes $0 and $5,405, respectively, to Ms. Carmen I. Bigles, our former Chief Executive Officer and sole Director of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Concentration of Credit Risk
9 Months Ended
Sep. 30, 2017
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk

Note I - Concentration of Credit Risk

 

At times cash deposited with financial institutions may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2017.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies
9 Months Ended
Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]  
Contingencies

Note J - Contingencies

 

The Company was contemplating a possible merger by the Company and Coquí. The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. No assurances can be given that the Company will be successful in pursuing a business combination in the near future or at all.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Deficit
9 Months Ended
Sep. 30, 2017
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit

Note K- Stockholders' Deficit

 

Pursuant to our Articles of Incorporation, our board has the authority, without further stockholder approval, to provide for the issuance of up to 10,000,000 shares of our preferred stock in one or more series and to determine the dividend rights, conversion rights, voting rights, rights in terms of redemption, liquidation preferences, the number of shares constituting any such series and the designation of such series. Our board has the power to afford preferences, powers and rights (including voting rights) to the holders of any preferred stock preferences, such rights and preferences being senior to the rights of holders of common stock.

 

During January 2017 to March, 2017, 48 shareholders of the Company, who previously acquired shares of the Company’s common stock, par value of $0.001 per share (The “SMSA Crane Shares”), in a private placement with the Company, at a price of $3.31 per share, entered into an share exchange agreement with Coqui. The 48 investors agreed to exchange their SMSA Crane Shares for an equal value of shares of Coqui’s common stock, par value $0.1 per share (the “Coqui Shares”), and Coqui agreed to proceed with the proposed share exchange. As a result, 1,663,443 SMSA Crane Shares outstanding held by these 48 shareholders and 151,300 outstanding warrants held by Pariter, the placement agent, were exchanged for Coqui Shares and Coqui Warrants and the Company cancelled these SMSA Crane Shares and warrants.

 

On May 16, 2017, the Board of Directors approved the issuance of 47,490 shares of its common shares to Coquí, based on the private placement share price of $3.31 in satisfaction for the total debt owed to Coqui of $157,194.

 

On June 26, 2017, our former controlling shareholder, Coqui Radio Pharmaceuticals, Corp. (“Coqui”), sold 9,947,490 shares of common stock to Irwin Eskanos for a purchase price of $250,000. See Note B - Changes of Control.

 

There were no preferred shares issued and outstanding at September 30, 2017 and December 31, 2016. There were 10,047,495 shares and 11,663,448 shares of common stock issued and outstanding as of September 30, 2017 and December 31, 2016, respectively.

 

Stock Warrants

 

The following table summarizes all warrant activity:

 

    Warrants    

Weighted

Average

Exercise

Price

   

Weighted Average

Remaining

Contractual

Life (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at December 31, 2016     151,300     $ 3.31       2.25        
Granted                        
Exercised                        
Cancelled     (151,300   $ 3.31              
Outstanding at September 30, 2017                        
Exercisable at September 30, 2017                        

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events
9 Months Ended
Sep. 30, 2017
Subsequent Events [Abstract]  
Subsequent Events

Note L- Subsequent Events

 

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)
9 Months Ended
Sep. 30, 2017
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.

 

Income taxes

Income taxes

 

The Company files income tax returns in the United States of America and various states, as appropriate and applicable.

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Company has adopted the provisions of ASC 740-10 "Accounting for Uncertain Income Tax Positions". The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a "more-likely-than-not" probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.

 

Income (Loss) per share

Income (Loss) per share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.

 

Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants).

 

Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position at the calculation date.

 

As of September 30, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. At September 30, 2017 there were 0 outstanding common stock warrants, which could dilute future earnings per share.

 

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

 

Going Concern

 

ASU 2014-15 – “Presentation of Financial Statements—Going Concern—Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”).” In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The updated accounting guidance was effective for the Company on December 31, 2016. We have implemented this new accounting standard and we will update our liquidity disclosures as necessary.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recently-Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 

Income Taxes

 

In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory ("ASU 2016-16"), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its financial statements.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Stockholders' Equity Note [Abstract]  
Schedule of Warrant Activity

    Warrants    

Weighted

Average

Exercise

Price

   

Weighted Average

Remaining

Contractual

Life (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at December 31, 2016     151,300     $ 3.31       2.25        
Granted                        
Exercised                        
Cancelled     (151,300   $ 3.31              
Outstanding at September 30, 2017                        
Exercisable at September 30, 2017                        

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Basis of presentation, Background and Description of Business (Details) - Coqui Radio Pharmaceuticals Corp [Member] - USD ($)
1 Months Ended 3 Months Ended
Oct. 31, 2013
Aug. 31, 2013
Oct. 31, 2013
Related Party Transaction [Line Items]      
Shares of common stock issued for cash 400,000 9,500,000  
Proceeds from issuance of private placement     $ 280,000
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Change of Control (Details) - USD ($)
9 Months Ended
Jun. 27, 2017
Sep. 30, 2017
Sep. 30, 2016
Change of Control [Abstract]      
Number of shares sold to buyer of company 9,947,490    
Total purchase price of shares sold to buyer of company $ 250,000    
Percentage of outstanding shares sold to buyer in purchase of company 99.00%    
Accounts payable paid by previous owner of company $ 130,000    
Forgiveness of debt recorded by company   $ 130,000
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Going Concern (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Going Concern [Abstract]          
Net Loss $ 12,166 $ 875 $ 55,014 $ 1,701  
Working capital deficits $ 12,000   $ 12,000   $ 244,000
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)
9 Months Ended
Sep. 30, 2017
shares
Accounting Policies [Abstract]  
Outstanding stock warrants, options or convertible securities which could be considered as dilutive for purposes of the loss per share calculation 0
Outstanding common stock warrants which could dilute future earnings per share 0
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Shareholder (Details) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Related Party Transactions [Abstract]    
Due to shareholder $ 39,115
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Former Shareholder (Details) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Due to Related Parties, Current [Abstract]    
Due to former shareholder $ 155,670
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Due to Related Party (Details) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Due To Related Party Details    
Due to Related Party $ 5,405
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Deficit (Narrative) (Details) - USD ($)
1 Months Ended 9 Months Ended
Jun. 27, 2017
May 16, 2017
Sep. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Class of Stock [Line Items]          
Preferred stock, shares authorized     10,000,000   10,000,000
Preferred stock, shares issued     0   0
Preferred stock, shares outstanding     0   0
Common stock, par value per share     $ 0.001   $ 0.001
Share price   $ 3.31      
Common stock, shares issued     10,047,495   11,663,448
Common stock, shares outstanding     10,047,495   11,663,448
Shares of common stock exchanged and cancelled     1,663,443    
Warrants cancelled     151,300    
Debt exchanged for stock   $ 157,194      
Debt exchanged for stock, shares   47,490      
Number of shares sold to buyer of company 9,947,490        
Total purchase price of shares sold to buyer of company $ 250,000        
Coqui Radio Pharmaceuticals Corp [Member]          
Class of Stock [Line Items]          
Common stock, par value per share       $ 0.1  
Share price       $ 3.31  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Deficit (Schedule of Warrant Activity) (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Dec. 31, 2015
Warrants      
Outstanding 151,300 151,300  
Granted  
Exercised  
Cancelled (151,300)    
Outstanding 151,300 151,300
Exercisable    
Weighted Average Exercise Price      
Outstanding $ 3.31 $ 3.31  
Granted  
Exercised  
Cancelled 3.31    
Outstanding $ 3.31 $ 3.31
Exercisable    
Aggregate Intrinsic Value      
Outstanding  
Granted  
Exercised  
Cancelled    
Outstanding
Exercisable    
Weighted Average Remaining Contractual Life (Years)      
Outstanding   2 years 2 months 30 days 3 years 3 months 4 days
EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 18 101 1 false 1 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://smsacraneacquisitioncorp.com/role/sscr-daei Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets Sheet http://smsacraneacquisitioncorp.com/role/sscr-bs Condensed Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://smsacraneacquisitioncorp.com/role/sscr-bsp Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations Sheet http://smsacraneacquisitioncorp.com/role/sscr-soo Condensed Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Condensed Statement of Cash Flows Sheet http://smsacraneacquisitioncorp.com/role/Statement-StatementsofCashFlows Condensed Statement of Cash Flows Statements 5 false false R6.htm 00000006 - Disclosure - Basis of Presentation, Background and Description of Business Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-BasisofPresentationBackgroundandDescriptionofBusiness Basis of Presentation, Background and Description of Business Notes 6 false false R7.htm 00000007 - Disclosure - Change of Control Sheet http://smsacraneacquisitioncorp.com/role/ChangeOfControl Change of Control Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements Summary of Significant Accounting Policies and Recent Accounting Pronouncements Notes 9 false false R10.htm 00000010 - Disclosure - Fair Value of Financial Instruments and fair value measurements Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-FairValueofFinancialInstrumentsandfairvaluemeasurements Fair Value of Financial Instruments and fair value measurements Notes 10 false false R11.htm 00000011 - Disclosure - Due to Shareholder Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-DistributiontoParentandRelatedPartyTransactions Due to Shareholder Notes 11 false false R12.htm 00000012 - Disclosure - Due to Former Shareholder Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-DuetoParent Due to Former Shareholder Notes 12 false false R13.htm 00000013 - Disclosure - Due to Related Party Sheet http://smsacraneacquisitioncorp.com/role/DueToRelatedParty Due to Related Party Notes 13 false false R14.htm 00000014 - Disclosure - Concentration of Credit Risk Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-ConcentrationofCreditRisk Concentration of Credit Risk Notes 14 false false R15.htm 00000015 - Disclosure - Contingencies Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-Contingencies Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Stockholders' Deficit Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-StockholdersEquity Stockholders' Deficit Notes 16 false false R17.htm 00000017 - Disclosure - Subsequent Events Sheet http://smsacraneacquisitioncorp.com/role/sscr-se Subsequent Events Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies) Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies) Policies http://smsacraneacquisitioncorp.com/role/Disclosure-SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements 18 false false R19.htm 00000019 - Disclosure - Stockholders' Equity (Tables) Sheet http://smsacraneacquisitioncorp.com/role/Disclosure-StockholdersEquityTables Stockholders' Equity (Tables) Tables 19 false false R20.htm 00000020 - Disclosure - Basis of presentation, Background and Description of Business (Details) Sheet http://smsacraneacquisitioncorp.com/role/BasisOfPresentationBackgroundAndDescriptionOfBusinessDetails Basis of presentation, Background and Description of Business (Details) Details 20 false false R21.htm 00000021 - Disclosure - Change of Control (Details) Sheet http://smsacraneacquisitioncorp.com/role/ChangeOfControlDetails Change of Control (Details) Details http://smsacraneacquisitioncorp.com/role/ChangeOfControl 21 false false R22.htm 00000022 - Disclosure - Going Concern (Details) Sheet http://smsacraneacquisitioncorp.com/role/GoingConcernDetails Going Concern (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-GoingConcern 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) Sheet http://smsacraneacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies 23 false false R24.htm 00000024 - Disclosure - Due to Shareholder (Details) Sheet http://smsacraneacquisitioncorp.com/role/DueToShareholderDetails Due to Shareholder (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-DistributiontoParentandRelatedPartyTransactions 24 false false R25.htm 00000025 - Disclosure - Due to Former Shareholder (Details) Sheet http://smsacraneacquisitioncorp.com/role/DueToFormerShareholderDetails Due to Former Shareholder (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-DuetoParent 25 false false R26.htm 00000026 - Disclosure - Due to Related Party (Details) Sheet http://smsacraneacquisitioncorp.com/role/DueToRelatedPartyDetails Due to Related Party (Details) Details http://smsacraneacquisitioncorp.com/role/DueToRelatedParty 26 false false R27.htm 00000027 - Disclosure - Stockholders' Deficit (Narrative) (Details) Sheet http://smsacraneacquisitioncorp.com/role/StockholdersDeficitNarrativeDetails Stockholders' Deficit (Narrative) (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-StockholdersEquity 27 false false R28.htm 00000028 - Disclosure - Stockholders' Deficit (Schedule of Warrant Activity) (Details) Sheet http://smsacraneacquisitioncorp.com/role/StockholdersDeficitScheduleOfWarrantActivityDetails Stockholders' Deficit (Schedule of Warrant Activity) (Details) Details http://smsacraneacquisitioncorp.com/role/Disclosure-StockholdersEquity 28 false false All Reports Book All Reports sscr-20170930.xml sscr-20170930.xsd sscr-20170930_cal.xml sscr-20170930_def.xml sscr-20170930_lab.xml sscr-20170930_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 45 0001553350-17-001214-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001553350-17-001214-xbrl.zip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